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Much remains unknown about non-motor symptoms of Parkinson’s disease (PD), which have variable occurrence,
progression, and severity among patients. The existing suite of neuroimaging tools has yielded insight that cannot
be garnered by traditional methods such as behavioral and post-mortem assessment. They provide information on
brain activity and structure that is invaluable to understanding abnormalities associated with neurodegeneration in
PD. Among these tools, functional magnetic resonance imaging (fMRI) is often favored for its safety and spatial
resolution. Resting state fMRI research capitalizes on the wealth of information that the brain offers when a person
is not performing a motor or cognitive task. It is also a good means to study impaired and heterogeneous populations,
such as people with PD. The present article reviews research that applies resting state fMRI to the ongoing hunt
for biomarkers of PD non-motor symptoms. Thus far, research in this subfield has focused on two of the most
common and significant non-motor symptoms: cognitive impairment and depression. These studies support
resting state fMRI as a valid and practical tool for the study of these symptoms, but discrepancies among findings
highlight the importance of further research with standardized procedures.
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A brain at rest is active, and understanding its spontaneous
neural activity has in the last decade been recognized as a
worthy pursuit [1-5]. Neuroscientists believe that brain
cells have the same metabolic system as those in the rest of
the body: they require more oxygen and glucose when
they are more active. Accordingly, a cluster of brain cells
that displays an increase in glucose and/or oxygen use is
believed to be more active than when it metabolizes less.
With these biological principles in mind, scientists can
exploit tools that measure differential glucose or oxygen
use in the brain to derive information on brain activity.
The least invasive method currently available is functional
magnetic resonance imaging (fMRI), which measures
blood oxygen level-dependent (BOLD) signals in the
brain. In fMRI, the brain is divided into hundreds to
thousands of voxels (3D version of pixels), and BOLD
signal oscillations within these voxels represent regional* Correspondence: klposton@stanford.edu
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article, unless otherwise stated.changes in brain activity. This makes it a valuable method
for researchers to observe brain function, and through ex-
perimentation, incrementally discover the underpinnings
of human consciousness and cognition [1,6].
Before scientists appreciated the vast insight that a rest-
ing state brain can yield, fMRI was used exclusively for
task-based studies, wherein participants perform scanner-
compatible assignments while BOLD signals are recorded
[6]. These usually involve manual responses to audio/
visual cues, which minimizes movement. With creative
design, task-based studies can target a wide array of mo-
toric, cognitive, and even psychological functions. How-
ever, they are limited by challenging ecological validity
and their dependence on participants’ ability to perform
the tasks [7,8]. Resting state (RS) fMRI research provides
avenues to discovering brain function, free of these con-
straints [1,2,7]. This is particularly relevant in studies of
older participants or impaired populations, such as people
with Parkinson’s disease (PD) [9]. In addition, RS fMRI
also provides contextually different information than
task-based studies. Namely, it reveals brain activity in
the absence of attention-demanding external stimulied Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 The default mode network (DMN). The DMN was
identified by applying FSL’s MELODIC independent component
analysis software (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/MELODIC) to the
group-level resting-state fMRI data from 15 participants aged 18–30
(see [29] for details of analysis methods). This network includes
clusters in the posterior cingulate cortex, precuneus, medial
prefrontal cortex, lateral parietal cortex, and the medial temporal
lobes (not shown).
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awake, and allow their minds to wander for up to ten
consecutive minutes while the resting state data is
acquired.
PD is one of many disorders to benefit from RS fMRI
research [11]. It is a neurodegenerative disorder with
many and heterogeneous symptoms, the most classic be-
ing bradykinesia, tremor, and rigidity [12,13]. While devel-
opment of Lewy-bodies in the substantia nigra and
associated loss of dopaminergic neurons are the definitive
pathological marker, the pathophysiologies of non-motor
symptoms are not well understood. The most common
and impactful of these non-motor symptoms are depres-
sion and cognitive impairment [14]. This article reviews
research efforts to understand these non-motor symptoms
of PD using RS fMRI.
Evidence suggests that human cognition results from
the dynamic interactions of distributed brain regions act-
ing together as a networks [6,15]. Using RS fMRI, multiple
canonical resting state networks have been described that
correspond to critical brain functions including move-
ment, language, episodic memory, and executive function,
to name a few [6,10,16,17]. The default mode network
(DMN) is currently the most studied network associated
with cognition and mood [7]. The term “default-mode” is
derived from the observation that specific brain regions
are consistently more active when the brain is at rest,
mind wandering, than during externally driven tasks
[3,4,10]. For this reason, it is sometimes called the task-
negative or task-free network [4]. The degree to which
DMN deactivates during a task depends partially on the
type and cognitive load of the task [6,10,18,19]. DMN
task-associated deactivation and rest-associated activa-
tion have been demonstrated to diverge from normal in
some neurodegenerative and neuropsychiatric disorders
[20-26]. For example, decreased DMN connectivity has
been proposed as a potential biomarker of Alzheimer’s
disease because it includes brain regions, such as the
posterior cingulate cortex (PCC), precuneus, and the
medial temporal lobes, that activate during episodic
memory retrieval tasks (Figure 1) [7,10,22]. Indeed, the
finding that DMN connectivity is reduced in Alzhei-
mer’s disease was one of the first clinical applications of
resting state fMRI. More recently, reduced DMN connect-
ivity has been demonstrated in patients with amnestic
mild cognitive impairment [27], leading researchers to in-
vestigate DMN connectivity changes associated with other
patient groups who exhibit amnestic cognitive changes,
such as PD. While DMN has been central to almost all RS
fMRI research on PD cognitive impairment to-date, it is
only one of several reproducible resting state networks
critical to human cognition [7,28]. Other examples of
well-studied cognitive RS networks include the executive
control network, where connectivity has been associatedwith executive task performance [17] and the visuospatial
network. In addition to DMN, other networks, such as a
prefrontal-limbic network, have been the primary focus
for depression research [26].
Review
Methods
The literature search for pertinent studies was conducted
using PubMed and PsycINFO. Varying combinations of
the following search terms were used in pursuit of these
studies: resting state, resting-state, Parkinson’s, fMRI,
functional magnetic, functional connectivity, default-
mode, non-motor, cognitive, cognition, depression, de-
pressed, mood, dementia. Relevant peer-reviewed studies
published or “in press” in English as of May 2014 were
included. Articles were excluded that did not address
non-motor symptoms and/or did not use resting state
fMRI. In addition, we required that studies include at
least one clinical descriptor of the non-motor symptom.
For instance, if a study examined the DMN it was included
if there was at least one clinical symptom described, such
as categorization of participants into cognitive categories
or a continuous cognitive variable. Twelve studies met our
criteria, and are discussed below.
RS fMRI analysis techniques
RS fMRI’s relative youth goes hand-in-hand with un-
knowns surrounding optimal analysis techniques. A range
of options exists, which approach the BOLD signal with
different goals [4]. In the study of PD, the most commonly
used technique for RS fMRI analysis is functional connect-
ivity (FC) [4,10]. Brain regions are considered functionally
connected to the extent that their low frequency BOLD
signals fluctuate in sync with one another, regardless of
spatial distance [2,4,30,31]. FC analyses are used to under-
stand the brain on a network level, and thus are highly
pertinent to RS fMRI research [31-33]. Region of interest
(ROI) FC analyses examine the connectivity of a specified
area with other specified regions (ROI-to-ROI), or with
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defined functionally by selecting an ROI of an area that
emerges from other relevant fMRI activation analyses, or
anatomically by selecting a brain structure of interest. ROI
FC is driven by previous research/hypotheses by nature of
its use of pre-defined “seed” regions. This results in
hypothesis-driven findings, but also limits the scope of the
research to preselected brain regions, therefore ignoring
potentially critical findings.
By contrast, a completely data-driven FC approach is
independent components analysis (ICA). ICA is a statistical
technique that separates a set of signals into independent
spatiotemporal components, which are uncorrelated and
non-Gaussian. When applied to RS fMRI, ICA disentangles
the combined fMRI signal into individual components,
which are then defined as networks [30,31]. Using ICA,
one can derive multiple resting state networks, such as
DMN or visuospatial network, from a group or individual’s
resting state scans. Another example of data-driven resting
state fMRI analysis is regional homogeneity (ReHo), which
evaluates the 4D activation of each voxel in context of its
directly-adjacent voxels [33,35,36]. The greater the similar-
ity among neighboring voxels in a scan’s duration, the more
regionally homogenous they are. If several touching voxels
exhibit near-identical fluctuations in BOLD signal, they rep-
resent a cluster of brain activity [33,35]. The utility of ReHo
lies in the (safe) assumption that brain activation is more
significant when a cluster is activated at the same time than
a single voxel [33,35,37]. ReHo does not concern the ampli-
tude of a voxel’s fluctuations; that is the territory of ALFF.
Amplitude of low frequency fluctuations (ALFF) analyzes
the activation intensity of each voxel in the resting brain by
summing the amplitude of its spontaneous fluctuations
[38-40]. ICA, ReHo, and ALFF are purely data-driven and
typically include the whole brain, which is advantageous
given science’s yet-immature picture of its intricacies. With-
out a priori assumptions limiting the analysis to specific
brain regions, these techniques are ideal for discovery of as-
sociations not previously detected. However, they can also
lack a hypothesis-driven approach and therefore are more
prone to false positive errors if the analysis does not include
strict correction for multiple comparisons. In addition,
these techniques can yield numerous results that can be dif-
ficult to deduce and are susceptible to interpretation errors.
The relative advantages and limitations of ROI versus data-
driven functional connectivity techniques are still a matter
of significant debate within the field, and are discussed in
detail elsewhere [41,42].
FC allows researchers to isolate and analyze brain net-
works, however it does not provide insight into the direc-
tionality of the network signals or the relative influence
that one region has over another. Effective connectivity
models have been developed to address this limitation and
allow for study of the dynamic interactions between brainregions. These models aim to understand the neural un-
derpinnings of cognition by using directed links, or edges,
to investigate the influence that one neuronal system
exerts over another, thereby revealing how cognitive
functions arise from interactions within and between
distributed brain areas [15,43]. One such technique that
has been used to understand cognitive dysfunction in
PD patients is graph theory, which enables connectivity
patterns of the whole brain and its connections to be
analyzed relative to one another [4,44,45]. This method
aims to capture both global and local information flow.
The theory mathematically represents regions of a net-
work as “nodes,” and direct connections between these
regions as “edges”. If two nodes share an edge, then they
are directly connected. Nodes that are indirectly con-
nected have longer “path lengths”, because two or more
edges are required to connect them. Hubs are nodes
that have large influence on information flow among
other intra-network nodes. While effective connectivity
approaches such as graph theory will likely aid in our
understanding of integrated brain functions, these tech-
niques have unresolved methodological issues. Chief
among them are the means of node selection and number
of nodes to use in analysis, which can significantly alter
results [46].
Cognitive impairment in PD
As with motor symptoms, PD patients are differentially
affected by cognitive symptoms – both in terms of symp-
tom subtype and symptom progression. Some degree of
cognitive impairment (CI) is almost inevitable in patients
who live long enough with PD [46-48], and cognitive defi-
cits can occur early in the disease [45-47]. While levodopa
and dopamine agonists can manage motor symptoms for
years and even decades, there are limited treatments for
CI in PD [49,50], and nothing is available to prevent or
delay cognitive symptoms. In addition, dopamine replace-
ment in PD can have variable effects on cognitive pro-
cesses, showing improvement or impairment depending in
part on the cognitive task being performed [51]. Hence,
patients and families often find CI to be a leading symp-
tom impacting quality of life [47]. Further, PD with mild
cognitive impairment is a risk factor for PD dementia [52],
although the neurobiological underpinnings leading to
dementia in PD are complex [53-55].
Advanced imaging techniques, such as RS fMRI, have
the potential to enlighten our understanding of PD CI
and aid in the development of novel treatment approaches
for this debilitating condition. However, there have been
several obstacles to RS imaging research inherent to PD
CI. For one, there were until recently no standardized
guidelines to which researchers could turn for a unified
operational definition [56,57]. Hence, CI meant different
things in different studies, making comparison between
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refer to all forms of cognitive deficit, including the various
domains and degrees of severity. We will specify the cog-
nitive domains tested within each study when possible,
but this raises the problem of small sample size used in
most RS fMRI research. Even when studies include
cognitive testing results, they are often too small for
comparisons between groups of patients with different
types (CI versus dementia) or domains of cognitive im-
pairment. As researchers start to use recommended
diagnostic criteria for the domains and severities of CI
along with larger sample sizes, the field can hope for
more cohesive findings. Lastly, there is uncertainty
within the scientific community regarding the effects
of dopamine on cognitive RS fMRI connectivity. Des-
pite these obstacles, researchers have begun to explore
RS fMRI as a means to better understand cognition in
PD patients.
Two studies used an ICA approach to study the rela-
tionship between resting state networks and cognition in
PD patients. Krajcovicova et al. studied non-demented,
non-depressed PD patients and healthy controls [58]. All
subjects underwent a structured neuropsychological bat-
tery that included assessment of memory, verbal fluency,
attention and orientation, speech, and visual–spatial
abilities. PD patients underwent all aspects of the study
ON their standard dose of PD medications. Applying
ICA to resting state data, the authors used a methodo-
logically rigorous combined-group approach to extract
DMN network connectivity from all subjects. They did
not find any differences in DMN connectivity between
PD and controls, nor did any of the behavioral tests cor-
relate with DMN connectivity. This study also used
task-based fMRI to examine DMN deactivations during
a visuospatial task, which were also not different be-
tween groups. However, they found that connectivity
within the PCC cluster of the DMN was stronger in pa-
tients who were on a higher dose of daily dopamine.
They did not find this correlation with disease duration.
The authors concluded that non-demented PD patients
did not have abnormal DMN connectivity, but noted
that dopamine medications may increase DMN con-
nectivity. They postulated that DMN connectivity might
be reduced in the dopamine deplete state, and then nor-
malized when patients were medicated. But they cau-
tioned that the hypothesis would need to be studied by
comparing the same patients OFF and ON dopamine
medications.
Also using ICA, Tessitore et al. included a modest
group of cognitively unimpaired, non-depressed PD pa-
tients and healthy controls, but the study yielded com-
pelling results [59] (Table 1). Patients were ON their
standard anti-parkinsonian medications during scan ac-
quisition and assessment. Although they used a relativelysimilar ICA technique to extract individual DMN con-
nectivity values, the researchers found different results
than Krajcovicova et al. They reported reduced DMN
connectivity in PD patients compared to healthy con-
trols, specifically within the right medial temporal lobe
and bilateral inferior parietal cortex . The authors clinic-
ally assessed three domains of cognition similar to those
assessed in the prior study: memory, executive function/
attention, and visuospatial ability. Unlike the prior study,
they found connectivity changes in DMN regions corre-
lated with individual performance in the cognitive tests.
Specifically, the authors found that increased right medial
temporal lobe connectivity was associated with better
memory performance and increased inferior parietal
cortex connectivity was associated with improved visuo-
spatial performance – despite overall memory and visuo-
spatial scores within the normal range. Although the
research was conducted before the 2012 diagnostic guide-
lines for PD-MCI were published, the study’s choice of
neuropsychological battery essentially reflected tests rec-
ommended in the three domains chosen. The authors
found no regions of increased DMN connectivity in the
PD group, and did not examine other RS networks. They
postulated that one or more of these other networks may
be differentially functionally connected in cognitively
unimpaired PD patients to compensate for decreased
DMN connectivity. Because global grey matter volume,
white matter volume, and CSF volume can confound RS
fMRI data, the authors confirmed that there were no
differences between groups in any of these measures.
Unlike Krajcovicova et al., this study suggests that ab-
normal DMN connectivity associated with memory per-
formance can be identified in PD patients ON dopamine
medications, and their findings complement other re-
search where PD dementia has been associated with ab-
normalities in the medial temporal lobe and parietal
cortices [60]. One possible explanation for the discrepancy
between these finding and earlier work is differences in
methodological approach. Krajcovicova et al. performed
the analysis using both groups in the same ICA dataset,
which increases the signal-to-noise ratio and is less prone
to false positive results. Indeed, Tessitore et al. caution
that their results be viewed as preliminary, given the less
rigid methodological approach, small sample size, lack
of comprehensive neuropsychological battery, and ON
dopamine medication scan assessments.
Two studies used an ROI-based analysis to investigate
functional connectivity changes in PD patients with de-
mentia. Seibert et al. compared RS FC in three groups:
cognitively unimpaired PD patients, healthy controls, and
patients with Parkinson-related dementia (PRD) [61].
They did not report the medication state of PD patients
during the scan. The third group included not only pa-
tients with PD dementia (PDD), but also those who had


















2011 ICA 18 PD (63.50; 9.07) ON PD (5.4; 0.31) Yes NR; NR
18 control (60.89; 6.67)
Seibert et al. 2011 ICA, 19 PD (72; 7) NR NR No NR; NR
VBM 18 PRD (70; 8)
19 control (76; 9)
Rektorova
et al.
2012 Seed FC 18 PD (63.5; 9.07) ON PD (4.44; NR) No NR; NR
14 PDD (72.36; 5.88) PDD (9.64; NR)





16 PD (64.15; 1.64) ON PD (5.4; 0.31) Yes NR; NR
16 control (65.5; 6.17)
Baggio et al. 2014 Graph
theory
43 PD no-CI (64; 9.8) ON PD no-CI (6.1; 4.4) Yes* Root mean square <0.3 mm




23 PD CI (66.7; 12.2) PD CI (9.0; 5.5)





30 PD (61.67; 9.46) Naïve Newly diagnosed, not
otherwise specified
No NR; NA




Yes < 2.5 mm displacement
and <2.5° rotation in
any direction.







14 control (64.1; 4.0)
NR: not reported, NA: not applicable. *A significant difference in Beck Depression Inventory scores were found between PD CI and HC that were controlled for in
some analyses.
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bined given the similar underlying pathologies despite
distinct clinical syndromes [57,62].
The authors used an ROI-to-voxel analysis to examine
FC using two anatomically-defined seed regions as rep-
resentative regions within specific resting state net-
works. They selected a PCC ROI (referred to as the
isthmus cingulate) to study the DMN, and the caudate
to study corticostriatal networks. The isthmus cingulate
yielded no significant or trending FC differences among
the three groups. In contrast to Tessitore et al. and
similar to Krajocoicova et al., they concluded no DMN
abnormalities in PD or PRD; however, it is plausible that
other DMN-related seeds would reveal otherwise, since
Tessitore et al. found connectivity changes in the medial
temporal lobe and parietal DMN regions, but not the
PCC. By contrast, the authors found significant corti-
costriatal network connectivity reductions between the
caudate seed and the bilateral superior frontal region,
bilateral caudal middle frontal region, and right putamen
in PRD patients compared to controls. PD patients with-
out dementia had no significant reductions compared to
controls, but exhibited FC patterns that fell between the
two other groups. This suggests that a continuum ofcorticostrial connectivity changes might exist among
healthy controls, cognitively normal PD patients, and
those with dementia. Studies that also include PD pa-
tients with mild cognitive impairment would strengthen
this hypothesis, as would longitudinal studies.
As with Seibert et al., Rektorova et al. used FC ana-
lyses to seek RS network differences among PD patients
with and without dementia, and healthy controls [63].
Participants were assessed ON their usual dose of anti-
Parkinsonian medications. The authors used a functionally-
derived PCC/precuneus ROI to evaluate DMN alterations,
and an anatomically-defined caudate ROI to examine
changes in what they termed an extrastriate visual RS
network. Similar to Seibert et al., the PCC ROI yielded
no significant FC differences across groups at rest. On
the other hand, the right caudate had reduced connectivity
with both right and left inferior occipital gyri in PDD com-
pared to controls, representing a changed extrastriate vis-
ual network. However, the observed areas of FC reduction
were in a posterior region that is often susceptible to sub-
stantial artifact. That the PDD group had significantly lon-
ger disease duration and older age than the other groups
was almost unavoidable, since both duration and age are
risk factors for development of dementia. The authors
YorkWilliams and Poston Journal of Clinical Movement Disorders 2014, 1:4 Page 6 of 12
http://http://www.clinicalmovementdisorders.com/content/1/1/4attempted to mitigate this confound by using age as a co-
variate of non-interest, which did not alter the results.
Two studies applied graph theory to RS fMRI data to
examine brain networks associated with PD cognitive
impairment. Baggio et al. examined network-level changes
associated with mild CI in PD while patients were ON
medications [44]. Similar but not identical to Tessitore
et al., they tested three domains of cognition: attention/
executive, visuospatial/visuoperceptual, and declarative
memory. Their analysis included PD CI patients, PD
no-CI patients, and healthy controls. Results showed
long-range connectivity reductions in both PD groups
and especially PD CI patients, who had reductions
among all major subcortical and cortical areas. Contrar-
ily, these groups displayed an increase in short-range,
particularly temporal and prefrontal interlobular con-
nections (again, especially in PD CI). These increased
short-range connections were negatively correlated with
visuospatial/visuoperceptual and declarative memory
performance in CI patients. Both PD groups, but espe-
cially CI, showed reduced hub importance and elevated
importance of nodes that were less important in HC
networks. This reorganization constitutes a shift in PD
from more efficient hubs to a reliance on local connect-
edness. Similar findings have been observed in RS fMRI
studies of Alzheimer’s disease [44,64]. This change may
be related to the high metabolic needs of such hubs,
which are inherently areas of greater activity [44,65].
Likely on account of the increased short-range connec-
tions, the reduced long-range connections in PD did
not affect overall global efficiency or characteristic path
length. Differing from results of similar Alzheimer’s dis-
ease research, Baggio et al. found that PD CI exhibited
increased modularity, which is a measure of how much
a network can subdivide into efficient subnetworks
(modules) [44], thus yielding a potential biomarker that
distinguishes CI in PD from Alzheimer’s disease. Study
strengths include the large sample size and sophisti-
cated, data-driven analysis technique. A potential limi-
tation includes a difference in head motion between
groups, which has been shown to confound findings in
other resting state studies [66]. However, this study
overall represents a sizable step forward in PD CI re-
search by identifying a potentially PD-cognition specific
network change, which merits further investigation.
Also using graph theory, Lebedev et al. studied a rela-
tively large group of 30 newly diagnosed PD patients, 18
of whom also underwent dopamine transporter imaging
[67]. All patients were dopamine-naïve, so scans and
cognitive assessments were performed in the OFF state.
They applied graph theory analysis using 90 cognitively
relevant ROIs to determine nodal strength associated
with cognition, again focusing on the memory, visuo-
spatial, and attention/executive domains. Using a PartialLeast Squares Regression they estimated the latent com-
ponents associated with each cognitive domain, and found
two cognition-associated components. One displayed bet-
ter memory performance associated with prefronto-limbic
nodes (specifically the orbitofrontal, anterior cingulate,
parahippocampal, and temporopolar regions), and the sec-
ond displayed better executive performance associated
with dorsal cortical nodes (dorsolateral prefrontal, frontal,
and parietal regions). In the latter, higher caudate dopa-
mine transporter binding was associated with increased
nodal strength, suggesting that relative preservation of
executive functions is associated with increased dopa-
minergic influence on dorsal cortical processing.
One study used ICA to investigate visual hallucinations
in PD [68]. While the authors did not specifically assess
cognitive deficits, we included the findings in our review
given the strong association between visual hallucinations
and dementia [46]. Yao et al. studied a small group of
non-depressed PD subjects with no visual hallucinations,
PD with visual hallucinations, and healthy controls (12 in
each PD group and 14 controls). The two PD groups were
well matched for disease duration, motor severity, and
daily levodopa dosage. They only included subjects with a
Mini-Mental State Exam score greater than 23 and the
average score was matched between the two PD groups;
however, this was the only cognitive test reported. All PD
patients were scanned ON dopamine medications. The
authors applied a dual-regression ICA technique and then
masked the data set to only examine regions within the
DMN. By only performing the between-group analysis in
the DMN-masked regions, they were able to limit the stat-
istical correction for multiple comparisons, but they lost
the ability to detect connectivity changes outside of DMN.
They found increased DMN connectivity in the right mid-
dle frontal gyrus and the bilateral PCC in the PD patients
with visual hallucinations compared to those without.
However, the severity of hallucinations on the Parkinson
Psychosis Rating Scale did not correlate with the relative
connectivity strength. The authors also found that both
PD groups showed lower DMN connectivity than the con-
trols, specifically in the bilateral medial prefrontal lobe
and the PCC/precuneus. The finding that PD patients
with visual hallucinations had greater DMN connectivity
than those without hallucinations is surprising since
hallucinations are often associated with more severe
cognitive impairment. However, the authors acknow-
ledge that they were unable to truly assess cognitive
function in the sample given the insensitivity of the
Mini-Mental State Exam to cognitive impairment in
PD. Similar to Tessitore et al., the authors report de-
creased DMN connectivity the PD groups, however they
hypothesize that reduced DMN connectivity may be at-
tributable to PD in general rather than secondary to
cognitive deterioration.
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with episodic memory changes in patients with amnestic
mild cognitive impairment and Alzheimer’s disease,
studies in PD patients thus far suggest that reduced
DMN connectivity is not associated with PD cognitive
impairment. There are several factors that might explain
these findings, however. First, it is interesting that stud-
ies focusing on the PCC did not find an association be-
tween DMN connectivity and PD cognition; by contrast,
the one study that found a relationship between PD cog-
nition and DMN only identified reduced connectivity in
the medial temporal and posterior parietal DMN regions.
In addition, no studies have examined DMN changes spe-
cifically in PD patients with and without amnestic CI,
which is important considering the relationship between
DMN connectivity and episodic memory impairment in
Alzheimer’s disease. Finally, while most studies controlled
for depression [44,58,59,68], a few did not [61,63,67]
(Table 1). Given the high prevalence of depression in
PD [69] and prior studies suggesting DMN connectivity
changes in depressed patients [70], it is critical that future
studies exploring DMN changes in PD patients control for
this potential confound.
The studies presented in this review highlight the im-
portance of examining networks other than DMN when
investigating PD cognition. Specifically, inferior parietal
connectivity changes associated with visuospatial perform-
ance found by Tessitore et al. and PD dementia related
connectivity changes between the caudate and frontal cor-
tex found by Seibert et al. suggest cognitive networks
other than DMN might be abnormal in PD cognitive
impairment. This is in line with findings that non-DMN
networks are impaired in other dementia syndromes,
such as behavioral variant frontotemporal dementia
[48,71]. In addition, functional imaging at rest using
18F-fluorodeoxyglucose positron emission tomography
has shown an abnormal network of glucose metabolism
in the pre- supplementary motor area, prefrontal cortex,
and parietal association regions associated with PD cog-
nitive impairment [12], suggesting that cortical regions
in non-DMN networks could contribute to PD associated
cognitive impairment. Whether non-DMN networks such
as the visuospatial network or executive control network,
for example, are abnormal in PD has yet to be explored.
Considering that PD cognitive impairment often occurs in
multiple domains, is it also likely that different networks
are related to different types of cognitive impairment,
which is supported by the findings of Lebedev et al. As
previously mentioned, this matter can only be resolved
using larger studies that include a thorough assessment of
all cognitive domains.
Several studies examined corticostriatal networks asso-
ciated with cognition in PD. Specifically, the findings by
Lebedov et al. suggest a distinction between dopaminemedicated executive performance associated with a dorsal
cortical network and a non-dopamine dependent network
associated with memory. The findings of both Rektorova
et al. and Seibert et al. demonstrated subcortical-cortical
connectivity reductions associated with PD dementia,
although one found caudate-frontal cortex deficits and
the other caudate-occipital cortex deficits. Using task-
based fMRI other studies have hypothesized a distinc-
tion between frontostriatal PD cognitive impairment,
which is milder and dopamine dependent, and posterior
(primarily parietal and temporal) PD dementia [72].
Overall, the studies discussed in this review support the
idea of dopamine dependent and non-dopamine dependent
cognitive networks in PD, and they suggest that RS fMRI
could be a useful tool in expanding our understanding
of how corticostriatal connections are associated with
different cognitive deficits. However, with one exception
[67] cognitive RS fMRI studies in PD patients thus far
have been performed ON medications and therefore
lack a study design to directly assess aspects of cognitive
RS networks that might be sensitive to dopamine.
Nevertheless, Krajcovicova et al.’s findings that DMN
connectivity correlated with daily dopamine dosage, but
not disease duration, suggests that cognitive RS net-
works can indeed be altered by dopamine. This is not
surprising since several studies have already identified
dopaminergic changes in PD motor resting state networks
[73,74], including dopaminergic connectivity changes be-
tween the basal ganglia network, the medial prefrontal
cortex and the precuneus [75]. It is conceivable that
dopamine could ‘normalize’ certain RS networks in PD
patients, but further perturb others. Future cognitively
focused studies in PD patients OFF and ON dopamine
will be an important next step given the dichotomous
clinical cognitive response to dopamine in PD.
Finally, the studies applying graph theory by both Baggio
et al. and Lebedev et al. suggest techniques that detect
strength and directionality of connectivity, rather than
simply network identification, might provide more ac-
curate understanding of PD cognitive circuitry. This is
especially important considering current interest in using
brain modulation techniques, such as deep brain stimula-
tion, to treat cognitive impairment [76]. It is plausible that
applying these effective connectivity techniques to RS
fMRI could assist in identifying ‘hubs’ of cognitive control
in PD that could be the target of direct stimulation
interventions.
Depression in PD
Depression is clinically relevant in approximately 35% of
people with PD and constitutes a major impact on pa-
tients’ quality of life [9,69,77]. Non-PD depression fMRI
research has yielded abnormalities in two RS networks:
the DMN and a prefrontal-limbic network that includes
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dala, palliostriatum, and the medial thalamus [26].
Within the DMN, findings include both increased and
decreased RS functional connectivity, even within the
same patients, suggesting a shift in network connectivity
rather than overall network suppression [70]. Within the
prefrontal -limbic network, studies have shown abnormal
functional connectivity specifically between the subgenual
anterior cingulate cortex and other limbic structures [78].
This is consistent with 18F-fluorodeoxyglucose positron
emission tomography studies showing the subgenual cin-
gulate region is metabolically overactive in treatment-
resistant depression, an insight that has led to exploration
of subgenual deep brain stimulation therapy for depres-
sion [79]. We will discuss the five RS fMRI studies that ex-
plore connectivity changes associated with depression in
PD. Overall, this research presents evidence of a disrupted
prefrontal-limbic network in depressed PD patients similar
to that in non-PD depression (Table 2).
Luo et al. published two studies assessing early-stage
PD patients with and without depression, along with
healthy controls [40,80]. They included only drug-naïve
patients, thereby controlling for the potentially cofounding
effects of chronic dopamine replacement therapy on
clinical symptoms and resting state brain activity. In
one study [40], they found that depressed PD patients
had higher ALFF in the left orbitofrontal cortex than
healthy controls and non-depressed PD patients. This
activity correlated positively with Hamilton Depression
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30 HC (51.9; 7.7)
Luo et al. 2014 Seed FC 52 PD (52.28; 9.41) Naïve
52 HC (51.17; 9.23)
Sheng
et al.





25 HC (56.7; 5.3)
NR: not reported, NA: not applicable.an increased orbitofrontal effort to control the limbic
system. The authors then chose 19 anatomical ROIs in
the prefrontal and limbic regions for an ROI-to-voxel
FC analysis, which revealed that depressed PD patients
had uniquely reduced connectivity between the left
orbitofrontal cortex and right insula. This prefrontal-
limbic disturbance was unrelated to motor symptom
severity, which was equal across the PD groups. The au-
thors also found that while both PD groups had reduced
connectivity between the putamen and the amygdala,
hippocampus, and other mesolimbic areas, depressed
patients exhibited additional reduced connectivity be-
tween the putamen and the left middle temporal gyrus.
Their other published study [80] reported complemen-
tary findings and used the Non-Motor Symptoms Scale.
They found that mesolimbic-striatal connectivity cor-
related significantly with the Non-Motor Symptoms
Scale scores. Specifically, decreased right amygdala con-
nectivity with the putamen was associated with higher
(more severe) global Non-Motor Symptoms Scale score
and mood subscore. No other specific non-motor sub-
scores correlated with connectivity. Luo et al. are the
only group thus far to report significant changes that
distinguish depressed PD from both non-depressed PD
and healthy controls.
Using ReHo analysis, Sheng et al. found regional
synchronization abnormalities associated with depression
in PD while patients were OFF dopamine medications
[35]. They then used regions with group differences in
ReHo for ROI-to-voxel FC analyses. Their cohort was notPD
PD Duration
(Years, mean; SD)
Head motion inclusion criteria;
between-group motion comparison
NR <1.5% coefficient of variance; NA
PD depressed
(6.4; 5.4)
<2 mm displacement each in translational or
rotational and <2° during whole scan; found no





<1.5 mm and <1.5° displacement in any direction;
found no significant differences between groups.
PD non-depressed
(2.12; 1.30)




<2 mm or 2°displacement in any direction;
no significant differences between groups.
PD non-depressed
(4.0; 2.4)
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Compared to non-depressed PD patients, they found sig-
nificant ReHo decreases in the left amygdala and bilateral
lingual gyrus, and ReHo increases in the left middle frontal
gyrus and right inferior frontal gyrus in the depressed
group. These increases are consistent with mood litera-
ture, where research has demonstrated resting state hyper-
activity in these regions [35,81]. The ROI-to-voxel FC
analysis revealed several differences among groups, which
are listed in Table 3. Notably, depressed patients had de-
creased left amygdala-prefrontal gyrus connectivity than
non-depressed patients, again in line with general depres-
sion research [34,35]. However, the authors did not find
significant connectivity differences between depressed PD
patients and healthy controls.
In addition to Luo et al., two studies applied ALFF to RS
fMRI to study connectivity in PD depression. Skidmore
et al. studied depressed and non-depressed PD patients
while OFF medications [38]. They found significantly in-
creased ALFF in the right subgenual cingulate cortex of
depressed patients, which correlated with higher (worse)
Hamilton Depression scores. The authors also found that
patients with high caregiver-rated apathy exhibited in-
creased right middle frontal gyrus ALFF and decreased left
supplementary motor region ALFF at rest, in addition
to the increased ALFF in the right orbitofrontal cortex
(which had slightly different peak coordinates from
the subgenual-focused depression marker). With this
Skidmore et al. went a step beyond the other groups
by finding an RS fMRI biomarker specifically for
caregiver-rated apathy. They concluded that there are
distinct abnormal networks associated with PD depression
and PD apathy, which is interesting in light of evidenceTable 3 Sheng et al.’s significant findings – functional




Amygdala – prefrontal gyrus
Right inferior frontal gyrus & left cerebellum
Right inferior frontal gyrus & right cuneus
Bilateral lingual gyrus & right superior frontal
gyrus




Right inferior frontal gyrus & right insula
Left middle frontal gyrus & right parietal gyrus
Right inferior frontal gyrus and left lingual gyrus
Bilateral lingual gyrus & bilateral median
cingulate gyrusthat selective serotonin reuptake inhibitor treatment for
depression might increase apathy in PD patients [82]. This
finding also has important implications in the develop-
ment of deep brain stimulation for PD mood disturbances
and suggests that different targets could differentially
affect depression and apathy [79].
Wen et al. studied depressed and non-depressed PD
patients OFF anti-parkinsonian medications, and healthy
controls [83]. The authors found that compared to non-
depressed PD patients, those with depression had de-
creased ALFF in the right dorsolateral-PFC, right
ventrolateral-PFC, and rostral anterior cingulate cortex –
all components of a prefrontal-limbic network. The
dorsolateral-PFC is generally credited for down-regulating
affective responses to negative situations, and its dysfunc-
tion is widely noted in depression research. The authors
also found increased ALFF in the right side of the cerebel-
lum in the depressed PD group. Despite these prefrontal/
cingulate discrepancies with the other studies, they found
higher ALFF in the dorsolateral-PFC was associated with
higher (worse) Hamilton Depression scores. Wen et al. did
not administer assessments of mood or cognitive function
in their control group, which is a limitation of the study.
Some consistent RS fMRI findings have emerged be-
tween PD and non-PD depression research. Both studies
by Luo et al. suggest that PD patients with depression
have decreased connectivity within the prefrontal-limbic
cortex previously identified in non-PD depression, and
specifically between the amygdala and putamen. Two
other studies found a relationship between increased
ALFF in the orbitofrontal cortex and clinical measures,
including caregiver-rated apathy [38] and patient-rated
depression [40]. Wen et al. also found a positive correl-
ation between increased ALFF and patient-rated depres-
sion, but only in the dorsolateral-PFC. Other findings
by Wen et al. diverge from PD and non-PD depression
research, such as PD depression-related decreases in
prefrontal-limbic ALFF; the authors did not explain this
seemingly paradoxical relationship (i.e., overall decreased
dorsolateral-PFC ALFF in PD depression, but a positive
correlation between dorsolateral-PFC ALFF and depres-
sion scores). Finally, it is unclear if connectivity changes in
PD-depression differ from those in non-PD depression be-
cause thus far RS fMRI studies have not directly compared
these two groups. While DMN connectivity changes have
been implicated in non-PD depression, this network was
not specifically assessed in the current PD RS fMRI de-
pression studies.
In general, the studies using RS fMRI to investigate de-
pression in PD control for several important confounds.
For instance, all studies concluded that no relationship
existed between depression-associated connectivity changes
and motor severity. Unlike the previously discussed
studies on PD cognitive impairment, all studies in
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tion state or in dopamine naïve patients and thereby
control for dopamine-associated changes in connectivity.
Finally, all studies report head motion exclusion criteria,
and all but one study specifies that there were no
between-group differences in movement (Table 2).
Conclusions
Resting state fMRI has emerged as an important tool in
the study of human cognition and emotion, and recently
has been applied to patients with PD in an effort to en-
lighten our understanding of these critical non-motor
symptoms. In general, these studies support RS fMRI’s po-
tential to be a valid and practical tool for the study of non-
motor symptoms in people with PD. Researchers acquired
high-quality RS fMRI data without signal degradation
from tremor or dyskinesias in both OFF and ON PD
medication states. Studies of PD cognition have suggested
that functional connectivity between different brain net-
works could be associated with impairment in different
cognitive domains. Studies of PD depression have sug-
gested functional connectivity changes in PD are similar
to those in non-PD depression, while a direct comparison
between these two groups has yet to be explored. Despite
these steps forward, discrepancies among results urge the
field to replicate studies with careful attention to several
methodological issues. The role of dopamine medication
on non-motor RS networks needs to be better explored,
particularly given the varying role these drugs play in non-
motor symptomatology and the clear association between
dopamine and RS motor network changes demonstrated
in prior studies [73,74]. Technical issues present another
barrier to cross-study comparability. Movement difference
between groups, and not simply total head movement, has
recently been shown to influence resting state results and
needs to be controlled carefully in PD patients (Tables 1
and 2) [66]. Larger studies in well-defined patient groups
according to published diagnostic criteria, along with de-
tailed demographic and clinical data, are necessary to in-
terpret and compare findings associated with patient
subgroups, such as PD-CI versus dementia and domain-
specific impairments. Finally, longitudinal studies are re-
quired to determine if any of these findings can be used to
predict future changes in PD cognition or mood. Studies
that attend to these issues could yield early clues of indi-
vidual patient risk for developing PD non-motor symp-
toms including cognitive impairment and depression, and
such biomarkers are the brass ring of PD research.
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